AGP Picks
View all

Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on November 16, 2026

Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032
Larimar Therapeutics Reports Third Quarter 2026 Financial and Business Update
NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates
MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights
MeiraGTx Announces Oral Presentation at ObesityWeek 2026
GT Biopharma Reports Third Quarter 2026 Financial Results
ToltIQ Chooses ABBYY for Parsing Complex Deal Documents
Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Noema Pharma Receives FDA Orphan Drug Designation for Basimglurant for the Treatment of Trigeminal Neuralgia
J-Star Holding Successfully Completes Advanced Composite Skin-to-Structure Welding Trials Built on Proprietary Manufacturing Technology
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results
Apptly Health Technologies Announces Strategic Partnership with BioTrax AI to Bring Precision Longevity Tools to Its Physician Network
Cardiff Oncology Receives FDA Fast Track Designation for Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer
Noom to Bundle a New Wearable, Noom Band, Into Its Popular Enterprise Obesity Care Programs at No Additional Cost
Bioxytran Turns Science into Everyday Wellness with Launch of Its First Two Nutraceutical Products 
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder
Medicenna Reports More than Doubling of Median Overall Survival in Glioblastoma Patients With Unresectable Recurrent IDH-WT Tumors Following One Treatment with Bizaxofusp Versus a Matched External Control at SNO 2026
Medline Inc. announces launch of secondary offering of Class A common stock

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Jordan Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.